Regulatory and medical service providers form a critical component of the broader pharma services ecosystem, supporting companies in navigating complex regulatory pathways, ensuring compliance, and generating the scientific and clinical evidence required for product approval and commercialization. These services span regulatory strategy and submissions, medical writing, pharmacovigilance, real-world evidence (RWE) generation, health economics and outcomes research (HEOR), and medical education, all of which require deep scientific expertise and strong integration with sponsor organizations. The segment operates in an environment characterized by evolving regulatory frameworks, increasing scrutiny, and the need to deliver high-quality, compliant outputs within compressed timelines. Geopolitical dynamics, including cross-border regulatory differences, data localization rules, and shifting healthcare policies, further influence service delivery models. As innovation accelerates in areas such as advanced therapies, digital health, and personalized medicine, service providers must continuously expand their capabilities, leverage data and digital tools, and maintain agility to meet the evolving needs of Pharma and Biotech clients.

We support these diverse pharma services providers across the full spectrum of strategic and operational capabilities. 

  • Corporate Strategy: we help define global ambitions, prioritize service portfolios across regulatory, pharmacovigilance, medical affairs, RWE, and medical education, assess market opportunities, and design scalable business models, including geographic expansion, partnerships, and integrated service offerings. 
  • Customer Insights: we map key stakeholders – including sponsors, regulatory authorities, healthcare professionals, and patients – capture the voice of clients, and refine value propositions to strengthen client acquisition, retention, and long-term partnerships. 
  • Commercial Strategy: we advise on go-to-market models, service launch readiness, commercial excellence initiatives, pricing and contracting frameworks, competitive benchmarking, and differentiation in a highly specialized and relationship-driven market
  • M&A and Transactions: we conduct commercial and vendor due diligence, support build-up and consolidation strategies, and manage acquisitions and post-merger integration to expand capabilities (e.g., PV, RWE, medical communications) and geographic reach
  • Organization and Transformation: we design governance models, target operating structures, and PMO frameworks to enhance operational efficiency, ensure compliance, and improve cross-functional coordination across scientific and regulatory teams
  • Digital, Data, and AI: e define digital roadmaps and deploy advanced analytics and AI use cases to enhance regulatory intelligence, automate medical writing, improve pharmacovigilance signal detection, and strengthen real-world evidence generation and insights

By combining deep sector expertise with end-to-end strategic and operational support, we help other pharma services providers strengthen operational resilience, enhance client value, navigate regulatory and geopolitical complexity, and achieve sustainable growth across global markets.